| Effects of Direct Current Brain Stimulation on Cognition (NCT00048698) | National Institute of Neurological Disorders and Stroke (NINDS) | 2002-11-01 |
| Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg (NCT00650065) | Mylan Pharmaceuticals Inc | 2002-11-01 |
| A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions (NCT00865241) | Actavis Inc. | 2002-11-01 |
| Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer (NCT00048893) | National Cancer Institute (NCI) | 2002-11-01 |
| Walking Therapy In Hemiparetic Stroke Patients Using Robotic-Assisted Treadmill Training (NCT00075283) | U.S. Department of Education | 2002-11-01 |
| The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients (NCT01878578) | Bial - Portela C S.A. | 2002-11-01 |
| Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma (NCT00048555) | Biogen | 2002-11-01 |
| Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers (NCT02253953) | Boehringer Ingelheim | 2002-11-01 |
| Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg (NCT00649597) | Mylan Pharmaceuticals Inc | 2002-11-01 |
| Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors (NCT00084708) | Roswell Park Cancer Institute | 2002-11-01 |
| Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases (NCT00060138) | Chugai Pharmaceutical | 2002-11-01 |
| Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer (NCT00083148) | Roswell Park Cancer Institute | 2002-11-01 |
| Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions (NCT01146093) | Dr. Reddy's Laboratories Limited | 2002-11-01 |
| A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions (NCT00864734) | Actavis Inc. | 2002-11-01 |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors (NCT00039481) | National Cancer Institute (NCI) | 2002-11-01 |
| Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver (NCT00035919) | University of Southern California | 2002-11-01 |
| Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg (NCT00649857) | Mylan Pharmaceuticals Inc | 2002-11-01 |
| Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer (NCT00050323) | Genzyme, a Sanofi Company | 2002-11-01 |
| Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose (NCT00577850) | Warner Chilcott | 2002-11-01 |
| Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers (NCT02587416) | NeuroBo Pharmaceuticals Inc. | 2002-11-01 |
| Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis (NCT01736696) | Pfizer | 2002-11-01 |
| A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients (NCT00653406) | Janssen Pharmaceutical K.K. | 2002-11-01 |
| Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer (NCT00050167) | M.D. Anderson Cancer Center | 2002-11-01 |
| Bioequivalence Study of Ibuprofen 200 mg Gel Capsules of Dr. Reddy's Laboratories Under Fasting Condition (NCT01149941) | Dr. Reddy's Laboratories Limited | 2002-11-01 |
| Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases (NCT00056966) | Baylor College of Medicine | 2002-11-01 |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer (NCT01897207) | Cantonal Hospital of St. Gallen | 2002-11-01 |
| Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma (NCT00116597) | University Hospital, Basel, Switzerland | 2002-11-01 |
| Therapy for Depression With Co-occurring Panic or Anxiety Symptoms (NCT00051207) | University of Pittsburgh | 2002-11-01 |
| CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto (NCT00251888) | ARCAGY/ GINECO GROUP | 2002-11-01 |
| Bioequivalence Study for Lamotrigine Tablets 200 mg Under Fed Condition (NCT01513681) | Dr. Reddy's Laboratories Limited | 2002-11-01 |
| To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours (NCT01951846) | Boehringer Ingelheim | 2002-11-01 |
| A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer (NCT00052000) | Millennium Pharmaceuticals, Inc. | 2002-11-01 |
| Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070) (NCT00945035) | Organon and Co | 2002-11-01 |
| Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg (NCT00650325) | Mylan Pharmaceuticals Inc | 2002-11-01 |
| Depsipeptide to Treat Thyroid and Other Advanced Cancers (NCT00048334) | National Cancer Institute (NCI) | 2002-10-26 |
| Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) (NCT00508443) | M.D. Anderson Cancer Center | 2002-10-25 |
| HIV-1 Vaccine Test in Uninfected Adult Volunteers (NCT00047931) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-17 |
| Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease (NCT00316498) | National Eye Institute (NEI) | 2002-10-17 |
| Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers (NCT01448070) | Novo Nordisk A/S | 2002-10-15 |
| Phase I/II Hypofractionated Radiotherapy for Prostate Cancer (NCT00214097) | University of Wisconsin, Madison | 2002-10-14 |
| Food Study of Midodrine HCl Tablets 5 mg and ProAmatine® Tablets 5 mg (NCT00648440) | Mylan Pharmaceuticals Inc | 2002-10-01 |
| Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer (NCT00046540) | INSYS Therapeutics Inc | 2002-10-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00053391) | University Hospital Erlangen | 2002-10-01 |
| Oxaliplatin in Rectal Cancer (NCT00259363) | Sanofi | 2002-10-01 |
| Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. (NCT00266708) | Montefiore Medical Center | 2002-10-01 |
| Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole (NCT01259115) | Purdue Pharma LP | 2002-10-01 |
| Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer (NCT00055770) | National Cancer Institute (NCI) | 2002-10-01 |
| Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions (NCT00841698) | Teva Pharmaceuticals USA | 2002-10-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00045149) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting Conditions (NCT01131923) | Dr. Reddy's Laboratories Limited | 2002-10-01 |
| Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia (NCT02215824) | Boehringer Ingelheim | 2002-10-01 |
| Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery (NCT01989559) | National Cancer Institute (NCI) | 2002-10-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00056134) | University Hospital Erlangen | 2002-10-01 |
| Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (NCT00045565) | National Cancer Institute (NCI) | 2002-10-01 |
| Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer (NCT02254005) | Boehringer Ingelheim | 2002-10-01 |
| Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg (NCT00649285) | Mylan Pharmaceuticals Inc | 2002-10-01 |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas (NCT00045708) | National Cancer Institute (NCI) | 2002-10-01 |
| Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer (NCT00047801) | Telik | 2002-10-01 |
| Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma (NCT00049712) | University of Wisconsin, Madison | 2002-10-01 |
| Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00052416) | Beth Israel Deaconess Medical Center | 2002-10-01 |
| Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes (NCT01082198) | Maria Sklodowska-Curie National Research Institute of Oncology | 2002-10-01 |
| Brain Reaction to Treatment of Nicotine Dependence (NCT00108173) | US Department of Veterans Affairs | 2002-10-01 |
| Brachytherapy in Treating Patients With Recurrent Malignant Glioma (NCT00045474) | National Cancer Institute (NCI) | 2002-10-01 |
| Role of Leptin in the Neuroendocrine and Immune Response to Fasting (NCT00140231) | Beth Israel Deaconess Medical Center | 2002-10-01 |
| Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies (NCT00048737) | M.D. Anderson Cancer Center | 2002-10-01 |
| Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia (NCT00040105) | M.D. Anderson Cancer Center | 2002-10-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in Children (NCT00494468) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2002-10-01 |
| Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg (NCT00649259) | Mylan Pharmaceuticals Inc | 2002-10-01 |
| Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants (NCT00228319) | Jeanne Drisko, MD, CNS, FACN | 2002-10-01 |
| Etanercept in New Onset Type 1 Diabetes (NCT00730392) | State University of New York at Buffalo | 2002-10-01 |
| Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg (NCT00648492) | Mylan Pharmaceuticals Inc | 2002-10-01 |
| Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer (NCT00049166) | National Cancer Institute (NCI) | 2002-10-01 |
| Brief Intervention for Families of Teens Treated in the Emergency Department for an Alcohol-Related Event (NCT00247221) | Brown University | 2002-10-01 |
| A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer (NCT00186108) | Stanford University | 2002-10-01 |
| Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg (NCT00650000) | Mylan Pharmaceuticals Inc | 2002-10-01 |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors (NCT00052780) | National Cancer Institute (NCI) | 2002-10-01 |
| Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma (NCT00057980) | Northwestern University | 2002-10-01 |
| Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer (NCT00047762) | Genentech, Inc. | 2002-10-01 |
| A Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution Formulation (NCT00601432) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-10-01 |
| Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer (NCT00055822) | The University of Texas Health Science Center at San Antonio | 2002-10-01 |
| Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck (NCT00318890) | University of Alabama at Birmingham | 2002-10-01 |
| Study of Saline Linked Monopolar Surface Radiofrequency (RF) Ablation of Hepatic Tumors (NCT00869843) | Washington University School of Medicine | 2002-10-01 |
| Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer (NCT00113581) | Merck KGaA, Darmstadt, Germany | 2002-10-01 |
| Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers (NCT00357383) | Laboratoires Thea | 2002-10-01 |
| Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors (NCT00054548) | National Cancer Institute (NCI) | 2002-10-01 |
| Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00054353) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00058396) | Memorial Sloan Kettering Cancer Center | 2002-10-01 |
| Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia (NCT00053248) | OHSU Knight Cancer Institute | 2002-10-01 |
| Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg (NCT00650312) | Mylan Pharmaceuticals Inc | 2002-10-01 |
| T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant (NCT00048464) | Xcyte Therapies | 2002-10-01 |
| Ke Ala Lokahi Demonstration Project for Sexual and Domestic Violence Prevention (NCT00164268) | Centers for Disease Control and Prevention | 2002-10-01 |
| VNP40101M in Treating Patients With Advanced or Metastatic Cancer (NCT00049699) | Vion Pharmaceuticals | 2002-10-01 |
| Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic Adults (NCT00839189) | University of North Carolina, Chapel Hill | 2002-10-01 |
| Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function (NCT01367561) | Bausch Health Americas, Inc. | 2002-10-01 |
| A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects (NCT02944487) | Idorsia Pharmaceuticals Ltd. | 2002-10-01 |
| Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects (NCT02211885) | Boehringer Ingelheim | 2002-10-01 |
| Study of Modafinil to Treat Fatigue in Persons With Traumatic Brain Injury (NCT00702637) | Craig Hospital | 2002-10-01 |
| Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients (NCT00052182) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (NCT00201682) | John Byrd | 2002-10-01 |